3Ferracin M, Pedriali M, Veronese A, et al. MicroRNA profiling for the identification of cancers with unknown primary tissue-of-ori- gin[]].The Journal of pathology, 2011,225 ( 1 ) : 43-53.
4Volinia S,Galasso M ,Costinean S,et al. Reprogramming of miR- NA networks in cancer and leukemia[J]. Genome Research ,2010, 20(5) :589-599.
5Trang P,Medina PP,Wiggins JF,et al. Regression of murine lung tumors by the let-7 microRNA[J]. Oncogene ,2010,29 (11 ) : 1580- 1587.
6Trang P,Wiggins JF,Daige CL,et al. Systemic delivery of tumor suppressor mieroRNA mimics using a neutral lipid emulsion in- hibits lung tumors in mice[J]. Molecular therapy:the journal of the American Society of Gene Therapy, 2011,19 (6) : 1116-1122.
7Chin LJ,Ratner E,Leng S,et al. A SNP ira a let-7 microRNA complementary site in the KRAS 3" untranslated region increases non-small cell lung cancer risk[J]. Cancer Research,2008,68 (20) :8535-8540.
8Paranjape T,Heneghan H,Lindner R,et al. A 3"-untranslated re- gion KRAS variant and triple-negative breast cancer:a case-con- trnl and genetic analysis[J]. The lancet ontology,2011,12(4):.377-386.
9Liu R,Chen X, Du Y,et al. Sermn microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic can- cer[J]. Clinical Chemistry ,2012,58(3 ) :610-618.
10Gao W,Lu X,Liu L,et al. MiRNA-21 :a biomarker predictive for platinum-based adjuvant chemotherapy response in patients with non-small cell lung cancer[J]. Cancer Biology & Therapy,2012,13 (5) :330-340.
